Cervical cancer risk perception and predictors of human papilloma virus vaccine acceptance among female university students in northern Nigeria

Journal of Obstetrics and Gynaecology

Volumn 30, Issue 8, 2010, Pages 857-862

  Iliyasu, Z ^a   Abubakar, I S ^a   Aliyu, M H ^b   Galadanci, H S ^a  

^a BAYERO UNIVERSITY   (Nigeria)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Cervical cancer; HPV; Nigeria; Predictors; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; AWARENESS; CANCER RISK; HEALTH EDUCATION; INTERPERSONAL COMMUNICATION; KNOWLEDGE; MEDICAL EDUCATION; NIGERIA; PRIORITY JOURNAL; STUDENT ATTITUDE; UNIVERSITY STUDENT; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; CARCINOMA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NIGERIA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; STUDENTS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 78649935718     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2010.511724     Document Type: Article

References (37)

1. Akinola OI, Fabamwo AO, Oshodi YA, Banjo AA, Odusanya O, Gbadegesin A et al. 2007. Efficacy of visual inspection of the cervix using acetic acid in cervical cancer screening: a comparison with cervical cytology. Journal of Obstetrics and Gynaecology 27:703-705.
2. Anhang R, Goodman A, Goldie SJ. 2004a. HPV communication: review of existing research and recommendations for patient education. CA: A Cancer Journal for Clinicians 54:248-259.
3. Anhang R, Wright TC Jr, Smock L, Goldie SJ. 2004b. Women's desired information about human papillomavirus. Cancer 100:315-320.
4. Antai D. 2008. Faith and child survival: the role of religion in childhood immunization in Nigeria. Journal of Biosocial Science 41:57-76.
5. Ayinde OA, Omigbodun AO, Ilesanmi AO. 2004. Awareness of cervical cancer, Papanicolaou's smear and its utilisation among female undergraduates in Ibadan. African Journal of Reproductive Health 8:68-80.
6. Babalola S, Lawan U. 2009. Factors predicting BCG immunization status in Northern Nigeria: a behavioral-ecological perspective. Journal of Child Health Care 13:46-62.
7. Buga GA. 1998. Cervical cancer awareness and risk factors among female university students. East African Medical Journal 75:411-416.
8. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003. Human Papilloma Virus types in invasive cervical cancer world wide: a meta-analysis. British Journal of Cancer 88:63-73.
9. Dekker AH. 2006. Fostering acceptance of human papilloma virus vaccines. Journal of American Osteopathic Association 106:14-18.
10. Denny L. 2008. Prevention of cervical cancer. Reproductive Health Matters 16:18-31.
11. Gharoro EP, Ikeanyi EN. 2006. An appraisal of the level of awareness and utilization of the Pap smear as a cervical cancer screening test among female health workers in a tertiary health institution. International Journal of Gynecologic Cancer 16:1063-1068.
12. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A et al. 2004. Efficacy of a bivalent L1 virus-like particle in prevention of infection with human papilloma virus types 16 and 18 in young women: a randomized controlled trial. Lancet 364:1757-1765.
13. Harper DM, Franco EL, Wheeler CM, Moscicki A, Rotch-Martins CM, Jenkins D et al. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papilloma virus types 16 and 18: follow up from a randomized controlled trial. Lancet 367:1247-1255.
14. Holcomb B, Bailey JM, Crawford K, Ruffin MT. 2004. Adults' knowledge and behaviours related to human papilloma virus infection. Journal of American Board of Family Practice 17:26-31.
15. Hoover DR, Carfioli B, Moench EA. 2000. Attitudes of adolescent/young adult women toward human papilloma virus vaccination and clinical trials. Health Care for Women International 21:375-391.
16. Jegede AS. 2007. What led to the Nigerian boycott of the polio vaccination campaign?. PL. S Medicine 4: e73.
17. Kabir M, Iliyasu Z, Abubakar IS, Mahboob S. 2005. Awareness and Practice of Cervical Cancer Screening among Female Health Professionals in Murtala Mohammed Specialist Hospital, Kano. Nigerian Postgraduate Medical Journal 12:179-182.
18. Kirwan JM, Herrington CS, Smith PA, Turnbull LS, Herod JJ. 2004. A retrospective clinical audit of cervical smears reported as 'glandular neoplasia'. Cytopathology 15:188-194.
19. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez F et al. 2002. A controlled trial of a Human Papilloma Virus type 16 vaccine. New England Journal of Medicine 347:1645-1651.
20. Kumar G, Howell R. 2000. Cervical glandular neoplasia. Obstetrician and Gynaecologist 2:43-45.
21. Lambert EC. 2001. College students' knowledge of human papilloma virus and effectiveness of a brief educational intervention. Journal of American Board of Family Practice 14:178-183.
22. Lenselink C, Schmeink C, Melchers W, Massuger L, Hendriks J, van Hamont D et al. 2008. Young adults and acceptance of the HPV. Public Health 122:1295-1301.
23. Lenselink CE, Gerrits MM, Melchens WJ, Massuger LF, van Hamont D, Bekkers RL. 2008. Parental acceptance of human papillomavirus vaccines. European Journal of Obstetrics and Gynaecology Reproductive Biology 137:103-107.
24. Lopez R, McMahan S. 2007. College women's perception and knowledge of human papilloma virus (HPV) and cervical cancer. Californian Journal of Health Promotion 5:12-25.
25. Lwanga S, Lemeshow S. 1991. Sample size determination in health studies: a practical manual. Geneva: World Health Organization. pp 23-41.
26. Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ et al. 2006. Efficacy of human papilloma virus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstetrics and Gynecology 107:18-27.
27. McPartland TS, Weaver BA, Lee SK, Koutsky LA. 2005. Men's perceptions and knowledge of human papilloma virus (HPV) infection and cervical cancer. Journal of American College Health 53:225-230.
28. Moraros J, Bird Y, Barney DD, King SC, Banegas M, Suarez-Toriello E. 2006. A pilot study: HPV infection knowledge and HPV vaccine acceptance among women residing in Ciudad Juárez, México. Californian Journal of Health Promotion 4:177-186.
29. Munoz N, Bosch F, de Sanjose S, Herrero R, Castellsague X, Shah KN. 2003. Epidemiologic classification of Human Papilloma Virus types associated with cervical cancer. New England Journal of Medicine 348:518-527.
30. NPC and ORC Macro. 2004. Nigeria Demographic and Health Survey 2003. Calverton, Maryland: National Population Commission (Nigeria) and ORC Macro. pp 169-172.
31. Okonofua F. 2007. HPV vaccines and prevention of cervical cancer in Africa. African Journal of Reproductive Health 11:8-9.
32. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H et al. 2003. Cancer in Africa: epidemiology and prevention. Lyon: IARC Press Publication No. 153. pp 23-25.
33. Richart RM. 1990. A modified terminology for cervical intraepithelial neoplasia. Obstetrics and Gynecology 75:131-133.
34. Schoolland M, Segal A, Allpress S, Miranda A, Frost FA, Sterrett GF. 2002. Adenocarcinoma in situ of the cervix. Cancer 96:330-337.
35. Vail-Smith K, White DM. 1992. Risk level, knowledge and preventive behaviour for human papilloma viruses among sexually active college women. Journal of American College Health 40:227-230.
36. Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R. 1999. University Students' knowledge and awareness of HPV. Preventive Medicine 28:535-541.
37. Yahya M. 2007. Polio vaccines - 'no thank you!' Barriers to polio eradication in Northern Nigeria. African Affairs 106:185-204.